§ Specialty

Plastic Surgery SEO

Plastic surgery SEO.

Abstract

The before-and-after gallery is the proof surface. The 45 CFR 164.508 specificity requirement applies to imagery separately from text testimonials. AMA Opinion E-9.6.1 plus state cosmetic-advertising overlays layer on top. Where injectables enter the page, FDA 21 CFR 202 enters with them. The page architecture has to carry all of it.

Book a diagnostic →

Plastic surgery is one of the high-margin specialty surfaces inside the Praxis medical SEO practice. The work integrates with the consent-workflow design, the schema layer, the directory reconciliation, and the GBP architecture for cosmetic-specialty practices.

What governs the surface

Four regulatory surfaces. Imagery, byline, advertising, injectables.

A plastic-surgery practice's marketing surface intersects federal HIPAA specificity on identifiable imagery, the Reviews System reading of ABMS specialty in author bylines, AMA E-9.6.1 layered with per-state cosmetic-advertising overlays, and the FDA boundary where injectables trade names enter the copy. Each one has a separate workflow.

Before-and-after-imagery consent under 45 CFR 164.508 specificity.

Identifiable before-and-after-procedure imagery is the load-bearing proof surface for a plastic-surgery practice's website. The 45 CFR 164.508 specificity requirement applies separately to imagery; a generic photo release does not satisfy the federal standard. The authorization names what gets disclosed (the imagery and any accompanying identifiers), who receives it, the purpose, the surfaces of use, the duration, and the patient's revocation rights. The ASPS Code of Ethics adds patient-image-use guidance that several state medical boards reference. We build the imagery-consent template against the federal floor plus the state overlay and route every gallery image through the workflow before it reaches a service page.

ABMS American Board of Plastic Surgery in the author byline.

The Reviews System 2023+ medical-content framework weights ABMS specialty alignment on first-party editorial content. A plastic-surgery practice publishing aesthetic-procedure articles needs the named author byline to surface American Board of Plastic Surgery certification with the active state license. Editorial content authored by a non-ABPS general physician on plastic-surgery procedures is the documented YMYL-demotion pattern. The Physician.sameAs chain on JSON-LD reaches the ABMS verification page, the NPPES (NPI registry) entry, and the state medical board licensure profile for every author on the site.

AMA Opinion E-9.6.1 advertising standards plus state cosmetic-advertising overlays.

AMA Code of Medical Ethics Opinion E-9.6.1 sets advertising standards binding the practice through state medical board incorporation. Several states overlay cosmetic-procedure-specific advertising rules. Florida testimonial-typicality representation, California Business and Professions Code testimonial-disclaimer rules, Texas Medical Board advertising standards. Multi-state practices clear the strictest market's bar on every page. We map the per-state rule overlay during the diagnostic and surface the disclaimers each state requires inside the on-page disclosure pattern.

FDA Section 502(n) on the boundary the practice does and does not cross.

Section 502(n) of the Federal Food Drug and Cosmetic Act governs prescription-drug advertising. A plastic-surgery practice marketing its own procedures (rhinoplasty, abdominoplasty, breast reconstruction) is not advertising a prescription drug and the FDA fair-balance framework does not bind the practice the way it binds a pharmaceutical manufacturer. When the practice surface mentions injectables (Botox, Juvederm, Restylane) by trade name, the surface crosses into FDA-regulated promotional copy under 21 CFR 202; AMA E-9.6.1 and state board rules still apply on top. The page architecture separates the two boundaries.

Side by side

The plastic-surgery surface on Praxis versus the default, on the four boundaries that matter.

Plastic-surgery practice on Praxis

ABPS-aligned + 164.508-scoped

Plastic-surgery practice on generalist SEO

Aesthetic-template default

Before-and-after gallery consent

Imagery-specific authorization template scoped per 45 CFR 164.508 specificity. Surfaces of use enumerated. Revocation surface designed. ASPS Code of Ethics patient-image guidance overlaid where the practice's state medical board references it.

Gallery images published under generic photo release. 164.508 specificity standard unmet for identifiable clinical imagery. ASPS guidance unread.

Author byline on aesthetic-procedure articles

American Board of Plastic Surgery certification surfaced. Physician.sameAs chains to ABMS verification, NPPES, state medical board licensure. Topic-to-specialty alignment audited per article.

Editorial content authored under generic agency byline or under an unspecified physician. Reviews System framework reads no practicing-ABPS reviewer signal.

Per-state cosmetic-advertising overlay

Florida testimonial-typicality, California Business and Professions Code disclaimer rules, Texas Medical Board advertising standards mapped during the diagnostic. Multi-state practices clear the strictest market on every page.

Single advertising posture across all states. Stricter markets carry rule violations the practice does not see until the medical board surfaces them.

Injectables copy (Botox, Juvederm, Restylane)

Trade-name surfaces flagged as FDA 21 CFR 202 promotional copy. Fair-balance pattern applied. AMA E-9.6.1 layered on top. State-board cosmetic-advertising rules layered on top of that.

Trade-name surfaces published without FDA promotional-copy discipline. Fair-balance pattern absent.

Schema markup on procedure pages

MedicalBusiness with availableService nodes naming the procedures. MedicalProcedure schema reserved for editorial content authored by ABPS-certified physicians. Manual-action risk on commercial pages documented and avoided.

MedicalProcedure schema applied to commercial pages selling rhinoplasty, abdominoplasty, breast reconstruction. Spammy-structured-data manual-action pattern is the documented outcome.

Testimonial workflow

45 CFR 164.508 five-element authorization for every patient quote. Identifiable testimonials carry the consent record before publication. De-identified case studies route through the 164.501 + 164.514 path separately.

Patient quotes shipped without consent record. Identifiable quotes carry HIPAA exposure the practice cannot evidence having authorized.

Plastic-surgery practice on Praxis

ABPS-aligned + 164.508-scoped

Before-and-after gallery consent: Imagery-specific authorization template scoped per 45 CFR 164.508 specificity. Surfaces of use enumerated. Revocation surface designed. ASPS Code of Ethics patient-image guidance overlaid where the practice's state medical board references it.
Author byline on aesthetic-procedure articles: American Board of Plastic Surgery certification surfaced. Physician.sameAs chains to ABMS verification, NPPES, state medical board licensure. Topic-to-specialty alignment audited per article.
Per-state cosmetic-advertising overlay: Florida testimonial-typicality, California Business and Professions Code disclaimer rules, Texas Medical Board advertising standards mapped during the diagnostic. Multi-state practices clear the strictest market on every page.
Injectables copy (Botox, Juvederm, Restylane): Trade-name surfaces flagged as FDA 21 CFR 202 promotional copy. Fair-balance pattern applied. AMA E-9.6.1 layered on top. State-board cosmetic-advertising rules layered on top of that.
Schema markup on procedure pages: MedicalBusiness with availableService nodes naming the procedures. MedicalProcedure schema reserved for editorial content authored by ABPS-certified physicians. Manual-action risk on commercial pages documented and avoided.
Testimonial workflow: 45 CFR 164.508 five-element authorization for every patient quote. Identifiable testimonials carry the consent record before publication. De-identified case studies route through the 164.501 + 164.514 path separately.

Plastic-surgery practice on generalist SEO

Aesthetic-template default

Before-and-after gallery consent: Gallery images published under generic photo release. 164.508 specificity standard unmet for identifiable clinical imagery. ASPS guidance unread.
Author byline on aesthetic-procedure articles: Editorial content authored under generic agency byline or under an unspecified physician. Reviews System framework reads no practicing-ABPS reviewer signal.
Per-state cosmetic-advertising overlay: Single advertising posture across all states. Stricter markets carry rule violations the practice does not see until the medical board surfaces them.
Injectables copy (Botox, Juvederm, Restylane): Trade-name surfaces published without FDA promotional-copy discipline. Fair-balance pattern absent.
Schema markup on procedure pages: MedicalProcedure schema applied to commercial pages selling rhinoplasty, abdominoplasty, breast reconstruction. Spammy-structured-data manual-action pattern is the documented outcome.
Testimonial workflow: Patient quotes shipped without consent record. Identifiable quotes carry HIPAA exposure the practice cannot evidence having authorized.

Updated 2026-05-28

How we engage

Diagnostic, then monthly retainer. Four phases, each scoped against cited deliverables.

Weeks 0-2

Diagnostic

We read your Search Console data, your traffic data, your current Schema.org markup, your physician author bylines, your testimonial pages, and your directory-profile completeness. The diagnostic comes back with the load-bearing pages, the dead weight, the YMYL-fragile content, and the entity-graph gaps. For multi-location groups, we add a GBP audit per practicing location.
Weeks 2-6

Schema and author layer

We build the MedicalBusiness and Physician schema layer with sameAs chains to NPI registry, ABMS verification, and state medical board profiles. Author bylines surface ABMS specialty and active state license alignment. CPT-aligned service pages where the procedure mix supports it. The schema layer reflects what each page actually is, MedicalCondition / MedicalProcedure types reserved for the editorial layer.
Weeks 4-8

Reviews System alignment

Editorial content rebuilt against the Reviews System 2023+ medical-content framework. Practicing-physician reviewer signals on first-party content. PubMed-cited primary literature replacing health-magazine summaries. Topic-to-specialty alignment in every author byline (a general practitioner does not author complex oncological articles). Patient testimonial workflow routed through the 45 CFR 164.508 consent path before any testimonial lands on a service page.
Monthly

Ongoing retainer

Monthly cadence on the rest of the site, plus content cadence for the queries the diagnostic surfaced. Quarterly review against your traffic data and Search Console movement. Re-audit of the entity-graph reconciliation when physician rosters change. Re-audit of the consent workflow when state medical board advertising rules change.

Common questions

Questions practice administrators ask before booking a diagnostic.

01.

Why is the before-and-after consent surface treated separately from the testimonial consent?

45 CFR 164.508 applies specificity per disclosure surface. Identifiable clinical imagery is a distinct identifiability surface from a text testimonial; the disclosure language, the surfaces of use, the duration of use, and the patient-reasonable-expectations test all differ. The federal floor requires the authorization to name what gets disclosed and where it appears, and a text-testimonial form does not cover imagery use. The ASPS Code of Ethics scopes patient-image use as a category meriting its own consent surface, and several state medical boards reference the ASPS guidance directly. We build the imagery template separately from the text-testimonial template and route every gallery image through the imagery workflow before publication.

02.

We market injectables alongside surgical procedures. Does that change anything?

The marketing surface crosses two regulatory boundaries. Surgical-procedure marketing (rhinoplasty, abdominoplasty, breast reconstruction) sits inside the state medical board + AMA E-9.6.1 + HIPAA mechanics; the FDA does not regulate the practice's own service marketing the way it regulates a manufacturer. Injectables surfaces (Botox, Juvederm, Restylane) reference branded prescription drugs whose advertising is regulated under FDA 21 CFR 202 and the Federal Food Drug and Cosmetic Act Section 502(n). The fair-balance requirement governs the trade-name copy. We separate the two pages architecturally so the surgical-procedure marketing does not inadvertently carry the unmet FDA pattern from an adjacent injectables page.

03.

Our ABMS-certified plastic surgeon authors all the editorial content. Is the byline enough?

The Reviews System 2023+ medical-content framework reads three load-bearing signals on first-party editorial: practicing-physician reviewer status, ABMS specialty alignment with the article topic, active state license. The byline surfaces the name; the JSON-LD Physician.sameAs chain ties the name to the ABMS verification page, the NPPES NPI registry entry, and the state medical board licensure profile. Without the chain, the framework reads the byline as an unverified claim. We bake the chain into JSON-LD on every author byline. The byline becomes the surface; the chain becomes the proof.

04.

Florida, California, Texas. Which state cosmetic-advertising rule controls?

All three when the practice operates in or markets into all three. Florida's testimonial-typicality requirement, California Business and Professions Code disclaimer rules, Texas Medical Board advertising standards each layer additional specificity on AMA E-9.6.1. The multi-state practice clears the strictest market on every page. The per-state rule overlay sits in the disclosure pattern at the page level. We do not state a strict-state rule as if it were federal; the per-state overlay is documented and the page-level disclosure carries what each state requires.

05.

Does Praxis author the medical-substance content?

We author the SEO architecture, the schema layer, the editorial structure, and the regulatory framing around clinical content. The medical-substance content (procedure descriptions, recovery patterns, candidacy criteria) is authored by the ABPS-certified surgeon at the practice, and the author byline reflects that. Praxis as an entity does not provide medical advice, and the disclaimer in the footer states it directly.

06.

How does this connect to the rest of our SEO work?

The plastic-surgery surface intersects four of the seven Tier 2 services: the HIPAA-compliant marketing work governs the testimonial and before-and-after workflow, the schema implementation reserves MedicalProcedure for editorial content and marks the commercial pages as MedicalBusiness with availableService, the directory work claims and reconciles the practice's Healthgrades and Zocdoc profiles for the surgical-specialty audience, and the local-pack work selects the GBP sub-category as Plastic Surgeon plus relevant medical-spa or cosmetic-procedure sub-categories where they apply.

Stop watching your competitors rank

If your before-and-after gallery shipped without imagery-specific consent, the workflow needs to land before the next page.

The diagnostic audits every gallery image against 45 CFR 164.508 specificity, every author byline against ABMS American Board of Plastic Surgery alignment, every injectables surface against FDA 21 CFR 202 fair-balance, and the per-state cosmetic-advertising overlay for every state the practice operates in.

Book a diagnostic → Email us